Capitalise on this ideal platform to market your publication and form strategic relationships through networking at the Targeted Cancer Therapy World Congress 2010 !
For more information on how your publication can profile as the industry leader, please contact Marcia Ardila on +44 (0) 207 539 4335 or email marcia.ardila@terrapinn.com
Meet our media Partners
European Journal of Cancer is an international comprehensive oncology journal that publishes original research, editorial comments, review articles and news on experimental oncology, clinical oncology (medical, paediatric, radiation, surgical), and on cancer epidemiology and prevention. Letters that comment on an article previously published in the EJC are also welcomed.
The next few decades will see dramatic changes within the field of oncology. Whilst the burden of disease is set to increase, the available armamentarium to the oncologist will be greater, more robust and offer the potential to focus on individual needs. Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community.
The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues, that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.
Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.
Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.
Future Medicine Ltd has developed an innovative publishing portfolio to reflect the advances in postgenomic medicine and to guide best clinical practice in modern medicine. Founded in 2004, Future Medicine Ltd is a privately owned publishing company headquartered in North London. Our journals are positioned at the forefront of modern medicine and are published according to industry-leading standards or peer review, presentation, speed of publication, online functionality and author service. Visit our website:
www.futuremedicine.com
Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.
SelectScience.net is the leading online product and application publication for laboratory scientists featuring the latest news, application articles, videos, product directory and product reviews. Membership is fast, free and provides access to all of the SelectScience services.
SelectScience.tv is a unique video news channel for laboratory application and product information.
Bentham Science Publishers, a major STM journal publisher of 90 titles and more than 200 open access journals in 2009, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Molecular Medicine (Impact Factor 5.254) and Current Medicinal Chemistry (Impact Factor 4.823) :
• FREE online journals and information:
www.bentham.org
• Subscribe, Consortia, discounted global licenses and trials:
marketing@bentham.org• To know more about our publications please visit :
http://bentham.org/Titlesbydiscipline.htm
This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena.
Oncology News is a unique FREE publication for cancer professionals, which provides reviews of oncology and related journals in a high quality glossy magazine format. Cancer care professionals value the magazine’s practical and accessible approach and, with a readership of over 6,750 specialists throughout UK, it is the most popular way to keep up-to-date on the latest news.
OVERVIEW
-
Each review is an independent specialist’s appraisal of an original paper, which is clearly referenced, allowing readers to return quickly to source material
-
Lead articles on topical issues, interviews with leading figures
-
Reviews of the latest books and websites
-
News from the conference scene
-
Comprehensive Diary listing section
-
Communication from readers themselves
For more information please visit our website:
www.oncologynews.biz
Since its launch in 1996,
Drug Discovery Today has been at the cutting edge of the science underpinning drug discovery and development. We deliver highly current reviews to our readers, not only addressing the rapid scientific developments in drug discovery associated technologies, but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
drugdiscovery today.com brings you:
Drug Discovery industry news at drugdiscoverytoday.com
Regular Editor’s Choice e-newsletter
Regular webinars
Drug Discovery Today digital magazine
Regular podcasts
Events Calendar
Bone Marrow Transplantation provides researchers and clinicians with original high-quality, peer-reviewed original research that addresses all aspects of basic biology and clinical use of hemopoietic stem cell transplantation.
Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, from bench to business, was introduced in 1981 as the first biotechnology trade publication. Now in its 28th year, GEN retains its position as the most widely read biotechnology publication around the globe.
Published 21 times a year, GEN's unique news and technology content focus includes the entire bioproduct life cycle from early-stage R&D to applied research and bioprocess through to commercialization. GEN is the only publication that provides the full range of the biotechnology market coverage in areas such as omics, drug and biomarker discovery, bioprocessing, clinical research, molecular diagnostics, and biobusiness.
